We showed earlier that p300/CBP plays an important role in G1 progression by negatively regulating c-Myc and thereby preventing premature G1 exit. Here, we have studied the mechanism by which p300 represses c-Myc and show that in quiescent cells p300 cooperates with histone deacetylase 3 (HDAC3) to repress transcription. p300 and HDAC3 are recruited to the upstream YY1-binding site of the c-Myc promoter resulting in chromatin deacetylation and repression of c-Myc transcription. Consistent with this, ablation of p300, YY1 or HDAC3 expression results in chromatin acetylation and induction of c-Myc. These three proteins exist as a complex in vivo and form a multiprotein complex with the YY1-binding site in vitro. The C-terminal region of p300 is both necessary and sufficient for the repression of c-Myc. These and other results suggest that in quiescent cells the C-terminal region of p300 provides corepressor function and facilitates the recruitment of p300 and HDAC3 to the YY1-binding site and represses the c-Myc promoter. This corepressor function of p300 prevents the inappropriate induction of c-Myc and S phase.
Introduction
The proto-oncogene c-Myc (referred to as Myc in this report) plays a pivotal role in the control of cell proliferation and its expression is deregulated in most forms of cancer (Dang, 1999) . Stringent regulation of Myc expression in normal cells is critical and is likely to be mediated at least in part by the chromatin remodeling complexes. The chromatin remodeling proteins p300 and CBP are two highly conserved nuclear phosphoproteins that are recruited by a large number of transcription factors to activate transcription. These proteins also contain intrinsic histone acetyl transferase activity that acetylates the nucleosomal histones and modifies the local chromatin structure to promote transcription (Goodman and Smolik, 2000) . Cell transformation by viral oncoproteins such as E1A is dependent on its binding to and inactivating p300/CBP (Frisch and Mymryk, 2002) . p300 is mutated in several forms of cancer suggesting a tumor suppressor role for this protein (Iyer et al., 2004) .
We previously showed that both p300 and CBP play an important role in quiescent cells by repressing Myc and preventing premature cell cycle G1 exit and that the repressive activity of p300 is not dependent on its HAT activity (Baluchamy et al., 2003 (Baluchamy et al., , 2005 . We also showed that E1A induces Myc in quiescent cells in a p300-dependent manner (Kolli et al., 2001; Baluchamy et al., 2007) . In this paper, we present evidence that in quiescent cells, p300 cooperates with transcription factor YY1 and histone deacetylase 3 (HDAC3) to repress the Myc promoter. p300 and HDAC3 associate with the Myc promoter upstream YY1-binding site resulting in the deacetylation of the Myc chromatin. YY1, p300 and HDAC3 bind to the Myc promoter YY1 site in vitro as a complex. The three proteins also form complexes both in vivo and in vitro. These and other results suggest that the C-terminal region of p300 provides an essential corepressor function in recruiting HDAC3 to the Myc promoter and keeping Myc in a repressed state in growth-arrested cells.
Results
Identification of p300 targets on human Myc promoter As p300 does not bind DNA directly, we reasoned that in quiescent cells a Myc promoter-specific transcription factor could recruit p300 and cooperate with deacetylase(s) to repress the promoter. To identify the p300 responsive elements, rat12 cells were transfected with Myc promoter-reporter constructs containing progressive deletions from the 5 0 end and maintained under serum-free medium for 48 h, then serum stimulated for 2 h and the luciferase activity was quantified. Note that in this report, rat12 cells were used for transient assays, whereas human breast epithelial cells (MCF10A) were used to study the endogenous Myc promoter. In our earlier studies, we used both MCF10A and rat12 cells to show that the endogenous Myc promoter is repressed by p300 (Baluchamy et al., 2003) . However, transfection efficiency of MCF10A cells is very poor and thus MCF10A cells could not be used for transient transfection assays. Data shown in Figure 1b indicate that a deletion mutant containing 647 bp upstream from the cap site (del-6) was efficiently repressed by p300 (the numbering is relative to the major P2 promoter start site; see Figure 1a ; Zou et al., 1997) . Although truncation of another 300 bp of the promoter resulted in a significant loss of basal activity, this mutant also lost its response to p300 indicating that transcription factors binding to sequences between À647 and À347 bp contribute to the repression of Myc by p300 (del-7; Figure 1b ). Previous studies in rat and mouse B cells have identified functional YY1 and Blimp1 sites abutting each other in the region between À350 and À450 bp of the Myc promoter (Figure 1a and d; Zou et al., 1997) . Mutagenesis of the putative Blimp1 site in the context of del-6 promoter did not affect repression by p300, whereas mutation of the YY1 site resulted in the complete loss of repression (plasmid YY1M, Figure 1c ). Electrophoretic mobility shift assays (EMSA) using nuclear extracts prepared from human MCF10A cells and an YY1-specific antibody showed that human YY1 protein binds to this sequence (supershifted band shown by an open arrow in Figure 1e ).
Note that in the absence of p300 overexpression the reporter activity of YY1M construct is similar to that of the WT plasmid even though repression in YY1M construct is relieved (Figure 1c ). We do not have a clear explanation for this at present. We assayed these plasmids 2 h after serum stimulation and it is possible that when stimulated with serum, in the absence of p300 overexpression, the YY1-mediated repression of Myc is relieved in the WT plasmid and thus both plasmids show similar levels of reporter activity. Nonetheless, under these assay conditions, when p300 is overexpressed, del-6 is repressed as efficiently as del-1 plasmid containing 2130 bp promoter sequences ( Figure 1b ) and p300 fail to repress when the YY1-binding site in del-6 is mutated (Figure 1c ).
Recruitment of p300 and HDAC3 to the YY1 site, transcription initiation and coding regions and their effect on chromatin acetylation Normally, the endogenous Myc promoter is minimally active transcriptionally and it is transiently induced after serum stimulation. We previously showed that the best way to study the repression of the endogenous Myc promoter by p300 is to overexpress p300 in quiescent cells then induce Myc by serum stimulation (Baluchamy et al., 2003) . Thus, we overexpressed FLAG p300 in quiescent human MCF10A cells, serum stimulated for 2 h to induce Myc and then performed ChIP assays with primer pairs that encompass the upstream 647 bp of the promoter sequences ( Figure 2a shows the time course). p300 is also reported to be associated with the transcriptional initiation and elongation complexes raising the possibility that in p300 overexpressing cells, increased levels of p300 may also be found in transcriptional initiation and coding regions (Black et al., 2006; Guermah et al., 2006) . Therefore, we also scanned three randomly chosen regions downstream of the RNA start site for p300 occupancy. A western blot shown in Figure 2c indicated that only p300 levels increased in p300 overexpressing cells. The occupancy of p300, YY1, HDAC1, -2 and -3 was quantified using real-time PCR with the primer pairs shown in Figure 2b . Changes in the levels of occupancy of these proteins in different regions of the promoter in p300 overexpressing cells as compared to that of control samples are shown as a bar diagram in Figure 2d (see legend to Figure 2d for further details). These data show that the occupancy of YY1 and p300 was enriched by about 10-and 5-fold, respectively, in the YY1-binding region (region II). A 20-fold increase in the occupancy of HDAC3 but not HDAC1 or 2 was also noted in region II. HDAC1 and 2 occupancy levels did not change in any of the regions tested, and in fact, they were slightly reduced in several regions (Figure 2d ). There was no increase in YY1 occupancy levels in any other regions of the promoter. There was also no change in p300 or HDAC3 occupancy Figure 1 Identification of the p300-responsive sequences on the human Myc promoter, and the YY1-binding site as a p300 target. (a) Map of the human Myc promoter and positions of YY1 and Blimp1 sites relative to the P2 promoter transcription start site. (b) Promoter-reporter assays using deletion constructs. Rat12 cells were transfected with the Myc promoter deletion constructs along with a p300 expression plasmid as described under Materials and methods. The vector DNA was included wherever appropriate to keep the DNA concentration constant. Luciferase units are shown for 5 mg of protein after normalizing with Rennila luciferase activity. Mean values from three independent experiments ±s.d. are shown. (c) Effect of YY1 and Blimp1 site mutations on repression by p300. Blimp1 and YY1 sites were mutated in the context of a deletion construct containing 647 bp from the P2 start site (del-6) and assayed as above. Note that these two sites are mutated in separate plasmids. YY1-M and Blimp-M refer to the plasmid constructs with mutations in YY1 and Blimp1 sites, respectively. (d) Comparison of the DNA sequences from À399 to À447 of the human Myc promoter with those of mouse and rat Myc promoters. The previously identified YY1 and Blimp1 sites of the mouse and rat Myc promoters and matching sequences in the human Myc promoter are underlined. Bases mutated in Blimp1 and YY1 sites are shown below the human sequence. (e) EMSA showing YY1 protein binding to the YY1 site. A 5 0 end-labeled double-stranded oligonucleotide containing the YY1 site was incubated in ice with 5 mg MCF10A nuclear extracts in an EMSA buffer and the DNA-protein complexes were resolved on 5% nondenaturing polyacrylamide gels at 4 1C (see Materials and methods). For super-shift assays, an a-YY1 antibody (H-414; Santa Cruz, Santa Cruz, CA, USA) was included during incubation. Open arrow shows the super-shifted complex. For competition assays, unlabeled probe was used at molar concentrations as indicated. YY1 refers to YY1-DNA complex and YY1m refers to mutant oligonucleotide as shown in (d). The sequence of the YY1-binding site probe is shown in (d).
p300 is a corepressor of c-Myc N Sankar et al levels in regions III and IV between control and p300 overexpressing cells (Figure 2d ). Region V was the only other promoter region that showed an increase in the p300 and HDAC3 occupancy levels (3.3-and 9-fold, respectively). Regions IV and V contain binding sites for transcription factors MAZ (Me1a2; Izzo et al., 1999) , E2F (Albert et al., 2001) , CTCF (Filippova et al., 1996) that function as repressors and also TBP (TATA box; see Figure 2b ).
However, these sites were not sensitive to p300 repression as transfection assays showed that promoter constructs with mutations on these sites continued to be repressed by p300 ( Figure 2e ). As reported earlier, deletion of the TATA box abolished the promoter activity (Albert et al., 2001) . The increased occupancy of p300 in region V is likely to be due to its association with protein complexes involved in transcription initiation, because p300 has been shown to be associated with the (Black et al., 2006) as well as with the C-terminal region of RNA polymerase II (Nakajima et al., 1997) . p300 occupancy was also enriched in regions VI, VII and VIII consistent with previous reports that p300 associates with proteins involved in transcription elongation (factor SII, for example, Guermah et al., 2006; see Discussion) . Interestingly, HDAC3 was also enriched wherever p300 was enriched, suggesting that p300 cooperates with HDAC3 by associating with proteins involved with transcription initiation and elongation. To rule out that YY1 indirectly assisted p300 to associate with chromatin in regions VII and VIII, probes corresponding to regions VII and VIII were tested in EMSA using extracts containing epitope tagged p300 and YY1. No DNA-protein complexes were generated in these assays suggesting that YY1 was not involved in the recruitment of p300 to these regions. Recent results indicate that methylation of histone H3 also represses gene expression (Schwartz and Pirrotta, 2007) . Preliminary ChIP assays using an antibody specific for H3K9 indicated that H3K9 methylation was not involved in the p300-mediated Myc repression (data not shown).
The acetylation levels for each region in p300 overexpressing cells as compared to normal cells were determined using antiacetyl antibodies that recognize acetylated H3 and H4 and relevant primer pairs. Data shown in Figure 2f indicate that acetylation was decreased in all the regions tested, although the degree to which the acetylation was reduced was variable and ranged from 30 to 90%. In summary, in p300 overexpressing cells, repression of Myc strongly correlates Effect of YY1, HDAC3 and p300 knockdown on their recruitment to the YY1 site, and chromatin acetylation Next, we examined whether the occupancy of HDAC3 and p300 on the YY1 site would be affected when the expression of p300 or YY1 is knocked down by small hairpin RNAs (shRNAs). Expression of the shRNAs specific for YY1, p300 or HDAC3 in quiescent cells led to a significant reduction in the accumulation of the relevant protein (Figure 3a) , Also, p300 shRNA expression did not affect the expression of CBP (Figure 3a) , YY1, HDAC1, 2 or 3 ( Figure 3b ). As shown in Figure 3c , p300 knockdown led to a 12-fold induction of Myc reporter activity (luciferase shRNA was used as control). Knockdown of YY1 and HDAC3 individually led to a sixfold induction of the Myc activity. Ablation of HDAC1 expression had no effect on the Myc activity. The increase in transcriptional activity of the Myc protein also correlated with the increase in Myc protein levels ( Figure 3d ). We previously showed that the changes in Myc protein and activity levels correlate with Myc RNA levels (Baluchamy et al., 2003 (Baluchamy et al., , 2005 . Under p300 knockdown conditions, neither p300 nor HDAC3 were detected at the YY1-binding site and YY1 was detected at much reduced levels. Likewise, when YY1 expression was blocked, there was no detectable occupancy of p300 and HDAC3 at the YY1-binding site ( Figure 3e ). ChIP assays as described above showed that there was an overall increase in the acetylation of chromatin H3 and H4 both in p300 and HDAC3 downregulated samples ( Figure 3f ). The acetylation of H3 and H4 in HDAC3 shRNA samples increased by about three-to fivefold in the regions tested. There was also an increase in the acetylation of the p300 shRNA samples although it was not uniform. The H4 acetylation in all regions was increased by about twofold, whereas increased H3 acetylation was evident for only regions II and V. Nonetheless, the increase in H4 acetylation in p300-depleted cells correlates with the increase in Myc expression.
Formation of a multiprotein complex containing YY1, p300 and HDAC3 with the Myc promoter YY1-binding site EMSA was carried out using nuclear extracts prepared from SaOS2 cells (we avoided the usual 293T or COS cells for extract preparation, as these cells contain E1A or large T that bind to p300) transfected with HA-p300, FLAG-YY1 and His-HDAC3 simultaneously and with an oligonucleotide containing the Myc promoter YY1 site. The gel was run until the YY1 DNA-protein complex migrated to the bottom of the gel (shown by an open arrow in Figure 4a ). When epitope-specific antibodies were used in the assays, several distinct super-shifted bands were visible whose identities could be established based on the migration of the complexes and the type of the antibodies used. For example, when a-FLAG antibody (YY1 specific) was included in the assay, a distinct super-shifted band appeared (C2), confirming the presence of YY1 in the complex (lane 2). Similarly, with HDAC3-specific a-His antibody a different super-shifted band appeared (C1), confirming the association of HDAC3 with the YY1-DNA complex (lane 4). It is interesting that the DNA-HisHDAC3 super-shifted band migrates faster than the DNA-FLA-GYY1. This may be due to unique conformation of these complexes or due to different stoichiometry of the antibodies binding DNA-protein complexes that alter the mobility of the complexes. When a-HA (p300 specific) antibody was included in the incubation mix along with a-FLAG antibody, a slowly migrating band near the origin appeared (C4, lane 5). Similarly, in the . Levels of p300, HDAC1, 2 and 3 and YY1 proteins in MCF10A cells infected with Adp300 vector. Serum starved cells were infected with Adp300 for 16 h, serum stimulated for 2 h then lysed and the proteins were analysed by western immunoblotting using antibodies as shown. The sources of the antibodies are: p300 (N-15), YY1 (H-414) and HDAC3 (B-10) were from Santa Cruz; HDAC1 (2E10) and HDAC2 (3F3) were from Upstate (Charlottesville, VA, USA). (d) ChIP assays showing increased occupancy of p300, HDAC3 and YY1 on the upstream YY1 site and increased occupancy of p300 and HDAC3 on the transcription initiation and coding regions of the human Myc promoter. The ChIP assay was carried out essentially as described in Materials and methods using primer pairs shown in the figure to generate about 150-200 bp products. The chromatin was immunoprecipitated with antibodies specific for p300 (N-15), YY1 (H-414), HDAC1 (2E10), 2 (3F3) and 3 (B-10) as shown and the amplified products were quantified by real-time PCR. Percent input for each region was calculated for control and experimental group and the fold change for p300 samples over control samples for each region were calculated. As additional controls, occupancy of all three proteins in each region were quantified using Immunoglobulin G antibodies and in p300 unresponsive region I. In both cases using real-time PCR, negligible quantities of DNA were recovered. The ChIP assay was repeated twice and the data shown are mean ± s.d. (e) Luciferase assays for plasmids with mutations in transcription factor-binding sites. The Me1a2 site that maps at À108 (GAGAAGGGCCAGGGC) was mutated in which two underlined bases were changed to TT using a site directed mutagenesis procedure. The E2F site located at À68 (TTGGCGGGA) was mutated such that the five underlined bases were changed to AATTC. The three underlined bases in the CTCF site located at þ 2 (CTAACTCGCTGTAGTAATTCCAGCGAG) were mutated to ACA. The TATA box mutation included a 6 bp deletion in the TATA box identical to that of the APA2 mutant described earlier (Albert et al., 2001) . (f) Bar diagram showing changes in H3 and H4 acetylations in promoter and coding regions in p300 overexpressing cells. The ChIP assays were carried out using primer pairs as shown in (b). The percent input for each region in control and the experimental samples were calculated as above. The values shown are the percent change observed for p300 overexpression samples for each region as compared to the corresponding regions of the control samples. The value for each control region was taken as 100%. Regions III and IV were not assayed. The ChIP assay was repeated twice and the data shown are mean ± s.d. p300 is a corepressor of c-Myc N Sankar et al presence of both a-HA and a-His antibodies, a band in the position of C4 was also observed (lane 7). The complex C4 appeared only when a-HA antibody was used indicating the presence of p300 in the YY1 complex along with HDAC3. When all three antibodies were included, the C4 band appears with much higher intensity (lane 8) when compared to those observed in lanes 5 and 7. This is most likely due to higher quantities of radioactivity super-shifted due to three antibodies in the assay. We could not detect a strong super-shifted band using only a-HA antibody perhaps because the epitope is burried in the protein (lane 3). However, a faint super-shifted band was visible on longer exposures (shown next to the Figure 4a) . Nonetheless, the presence of p300 in the complex was confirmed because the complex C4 (lanes 5, 7, and 8) appears only when a-HA antibody is used in the assay. Furthermore, C4 complex shown in Figure 4a is not the result of an artifact due to HA antibody added to the assay, as addition of anti-HA antibody to the EMSA using extracts containing only His-HDAC and FLAG-YY1 did not generate C4 complex ( most likely are due to the presence of a portion of the complexes that contain only YY1 and HDAC3. The specificity of these bands was further confirmed in EMSA using nuclear extracts prepared from cells transfected with the expression plasmids described above in various combinations as well as incubating the probe with antibodies alone (data not shown). Together, the above data indicate that much of the DNA-YY1 complex also contains HDAC3 and p300 and strongly argue that HDAC3 and p300 are associated with YY1 protein that is bound to the Myc promoter YY1 site.
p300 interactions with YY1 and HDAC3 in vivo and in vitro Co-immunoprecipitation experiments using cell extracts prepared from quiescent MCF10A cells indicated that the three proteins form a complex in vivo. For example, anti-p300 antibody can co-immunoprecipitate both YY1 and HDAC3 from cell extracts prepared from quiescent cells (Figure 5a ). Similarly, both p300 and HDAC3 were co-immunoprecipitated by an anti-YY1 antibody indicating that these three proteins are likely to be present as a complex in vivo.
Further, any two of these three proteins can be coimmunoprecipitated using extracts prepared from cells in which expression of the third protein is knocked down using appropriate shRNAs ( Figure 5b shows the levels of the three proteins in extracts prepared cells expressing relevant shRNAs). For example, ablation of p300 expression did not affect the formation of YY1-HDAC3 complex (Figure 5c , Luc-sh refers to control). Similarly, ablation of YY1 expression did not affect formation of the p300-HDAC3 complex and ablation of HDAC3 expression did not affect p300-YY1 complex formation. Taken together, these results suggest that the three proteins can form a ternary complex in vivo.
To further study the protein-protein interactions, we employed glutathione S-transferase (GST) pull-down assays. When GST-YY1 was incubated with radiolabeled HDAC3, significant quantities of HDAC3 bound to GST-YY1, consistent with a previous report (Figure 5d ; Yao et al., 2001) . Similarly, as reported previously, only the C-terminal region of p300 (amino acids (aa) 1572-2370) bound to GST-YY1 (Figure 5d ; Lee et al., 1995) . Direct interactions between HDAC3 and the C-terminal region of p300 could be demonstrated by incubating the GST-p300 with radio-labeled HDAC3 or GST-HDAC3 with radio-labeled p300C (Figure 5e ). When GST-YY1 beads were incubated with HDAC3 and the C-terminal region of p300 simultaneously, YY1 bound to both p300 and HDAC3 indicating a direct interaction of YY1 with p300 and HDAC3 (Figure 5f ).
To confirm that p300 can bind to YY1 and HDAC3 simultaneously, we used a mutant of YY1 in which aa 170-200 deleted. Published results show that in vivo two regions of YY1 (aa 170-200 and 261-333) are involved in YY1-HDAC3 interactions, whereas in vitro YY1 uses only aa 170-200 region for binding to HDAC3 (Yao et al., 2001) . Therefore, GST-YY1D170-200 immobilized on GST beads should not bind to HDAC3. If both HDAC3 and p300 can be recovered from GST-YY1D170-200 beads, it would indicate that p300 can simultaneously bind to both YY1 and HDAC3. Accordingly, GST-YY1D170-200 was immobilized on GST beads and incubated with radio-labeled HDAC3 and p300C in various combinations. As shown in Figure 5g , beads containing GST-YY1D170-200 bound to radio-labeled p300C but not HDAC3 (lanes 2 and 4). In contrast, when GST-YY1D170-200 was incubated with labeled HDAC3 and p300C simultaneously, significant amounts of both HDAC3 and p300C could be recovered from the beads (lane 6). These results show that at least in vitro, p300 can bind to both HDAC3 and YY1 simultaneously. p300 cooperation with HDAC3 and YY1 in Myc repression In transient assays p300 and HDAC3 together was more effective in inhibiting the Myc promoter than either plasmid alone indicating that p300 and HDAC3 cooperate with YY1 in repressing the Myc promoter p300 is a corepressor of c-Myc N Sankar et al (see Supplementary Figure 1 for further details). Similar cooperative effect was observed between YY1 and p300 in inhibiting the Myc promoter. In contrast to HDAC3, HDAC1 had only a modest effect in this assay, while HDAC2 had no effect at all. Western immunoblotting showed that the three proteins were expressed at similar levels. Thus, consistent with ChIP assay results shown in Figure 2d , only HDAC3 cooperated with p300 at significant levels in repressing Myc promoter.
Role of SUMO modification of p300 in Myc repression
Others have shown that p300 contains a transcriptional repression domain also known as cell cycle regulatory domain (CRD domain) that is dependent on sumoylation of the two sumoylation sites between aa 1004 and 1045 (Girdwood et al., 2003) . Transient transfection assays using a mutant p300 in which the two SUMO modification sites were deleted (aa 1004-1045) showed that this mutant repressed the Myc promoter as efficiently as the WT p300 (Figure 6a and b shows different p300 domains and the structure of the p300 mutants). Data shown in Figure 5 suggest that both YY1 and HDACs bind to the C-terminal region of p300 downstream of the sumoylation sites (also see Lee et al., 1995) . These observations prompted us to examine whether the C-terminal half of p300 would be sufficient to repress Myc. Data shown in Figure 6c indicate that the C-terminal half of the protein (aa 1145-2414) repressed the Myc promoter as efficiently as the fulllength p300. The N-terminal half of p300 (aa 1-1301) did not show any repressive activity. Western blots showed that the truncated forms of p300 were expressed efficiently in transiently transfected cells (Figure 6d ). These results suggest that the Myc repressive activity of p300 resides in the C-terminal half of p300.
Discussion
In this paper, we showed that p300 cooperates with HDAC3 at the Myc promoter YY1-binding site to repress the promoter. HDAC3 recruitment to Myc chromatin correlated with chromatin deacetylation and reduced Myc expression. These results provide a mechanistic explanation for the changes in Myc expression when p300 levels are altered in the cell. The repressive activity of p300 is not dependent on its intrinsic HAT activity (Baluchamy et al., 2003) or the SUMO modification and it is associated with the C-terminal half of p300 to which the transcriptional repressors YY1 and HDAC3 bind (Figures 5 and 6) . Thus, it is likely that the C-terminal half of p300 serves as a corepressor and facilitates the recruitment of HDAC3 to the YY1 site.
The endogenous Myc in quiescent cells is minimally active transcriptionally. Thus, to study the mechanism of Myc repression in its natural context, we overexpressed p300 in quiescent cells and then serum stimulated to transcriptionally induce Myc. Under these conditions Myc is partially repressed (Baluchamy et al., 2003) . Therefore, increased occupancy of p300 on the Nuclear extracts were prepared from SaOS2 cells transfected with plasmids expressing FLAG-YY1, HA-p300, and His-HDAC3, and 2 mg protein was incubated with a 5 0 end labeled double-stranded oligonucleotide containing the YY1 site. For super-shift assays, antibodies specific for the epitopes were added to the assay (see Materials and methods). The gel was run until the YY1-DNA protein complex reached to the bottom of the gel (4 h) to resolve different high molecular weight complexes, dried and autoradiographed. A darker exposure of the first four lanes of the gel shown in (a) is shown next to (a). Sources of the antibodies were: a-HA (12CA5), a-FLAG (M2; Sigma, St Louis, MO, USA) and a-His (sc-803; Santa Cruz). (b) EMSA showing that complex C4 does not appear in the absence of HA-p300 in the extracts. EMSA was carried using nuclear extracts prepared from cells transfected with FLAG-YY1 and His-HDAC3 expression plasmids and incubated with YY1-binding site and antibodies as shown. In vitro translated HDAC3 or the N-terminal (p300N, amino acids (aa) 1-596), middle (p300 M, aa 744-1571), and the C-terminal fragments of p300 (p300C, aa 1572-2370) were incubated with GST-YY1 in separate incubation reactions and the bound proteins were identified by SDS-polyacrylamide gel electrophoresis (PAGE) followed by autoradiography. Expression of GST proteins in each case was confirmed by SDS-PAGE followed with Coomassie blue staining (data not shown). (e) Binding of HDAC3 and the C-terminal region of p300 in vitro. GST-p300C was incubated with in vitro labeled HDAC3 (left) or vice versa (right) and the bound proteins were identified as above. (f) Binding of both p300C and HDAC3 to YY1 in vitro. GST-YY1 was incubated with in vitro labeled p300C and HDAC3 together and the bound proteins were identified as above. Methionine-labeled HDAC3 and the three p300 fragments used in the binding assays shown in (c and d) were loaded on to the gel. After electrophoresis the gel was dried and autoradiographed. p300 is a corepressor of c-Myc N Sankar et al TATA box and the coding regions is consistent with the recently published results showing that p300 associates with transcriptional initiation and elongation factors during gene transcription (Black et al., 2006; Guermah et al., 2006) . Thus, it appears that the corepressor function of p300 is extended to the transcription initiation and coding regions where p300 appears to facilitate the recruitment of HDAC3 to the chromatin. We believe that the primary role played by p300 in repressing the Myc promoter is the recruitment of HDAC3 to the YY1-binding site. This is based on the observation that p300 fails to repress a promoter construct in which YY1 site is mutated (YY1-M in Figure 1 ).
Although CBP was present in p300-depleted cells at normal levels, it did not compensate for p300 in repressing Myc in p300 knockdown cells (Figure 3) . This is consistent with our previously published data showing that normal levels of both p300 and CBP are required for the repression of Myc in quiescent cells (Rajabi et al., 2005) . In addition, published reports show that in vivo, these two proteins are present in limiting amounts and that they show dose-dependent effects on normal cell proliferation and development (Yao et al., 1998; Kung et al., 2000; Iyer et al., 2007) .
It is at present unclear what factors contribute to the increased Myc chromatin acetylation in p300 depleted cells (Figure 3 ). One possibility is that when the repressor complex is removed from the Myc promoter, the chromatin undergoes changes such that it is poised for acetylation by other acetylases such as CBP and GCN5/PCAF. Using a recent literature survey, we did not find a situation exactly similar to that reported here. However, others have shown that the interferon-b promoter acetylation by GCN5/PCAF when p300 or CBP is depleted (Agalioti et al., 2002) .
It is noteworthy that HDAC1 and 2 are not involved in p300 mediated repression of Myc. Studies have shown that HDACs exist as distinct multi-subunit complexes with HDAC3 present in one complex while HDAC1 and HDAC 2 are found together in a separate complex (Hassig et al., 1998; Zhang et al., 1999) . At present is unclear whether p300 is a part of the HDAC3 containing complex in quiescent cells.
In p300 depleted cells, we found reduced occupancy of YY1 on the YY1-binding site as compared to normal cells (Figure 3e ). This may be due to reduced affinity of YY1 to the YY1-binding site in the absence of p300 as it has been suggested that YY1 may be present in cells as a complex with p300 (Lee et al., 1995) . It may not be related to changes in the DNA binding activity of YY1 due to p300 mediated acetylation (Yao et al., 2001) as the HAT activity of p300 is not involved in the repression mechanism.
The repressive properties of p300 that we describe here are consistent with a corepressor role for p300 in transcriptional repression (Santoso and Kadonaga, 2006) . In several other cases the mechanism of repression of gene expression by p300 appears to be indirect (Munshi et al., 1998; Waltzer and Bienz, 1998; Poizat et al., 2000; Hong and Chakravarti, 2003; Guidez et al., 2005) . However, our studies show that p300 plays a more direct role at the chromatin level in repressing Myc. Currently we do not know whether p300 also plays a role in the YY1 mediated repression of other promoters. The c-Fos promoter has been shown to be repressed by YY1 (Murphy et al., 1999) . However, our previously published results show that in the context of G1, the c-Fos promoter is not repressed by p300 overexpression (Baluchamy et al., 2003) . p300 may play an essential role in cell cycle progression by co-activating a number of cell cycle related transcription factors (Goodman and Smolik, 2000) . Thus, it is tempting to speculate a repressor role for p300 that is similar to that of Rb. That is, in quiescent cells, an underphosphorylated form of p300 in association with chromatin repressor complexes may repress gene expression. During G1-S transition, growth factors stimulation may phosphorylate p300 (Yaciuk and Moran, 1991) leading to the dissociation of YY1 and HDAC3 from the complex and gaining its acetylase function to activate transcription.
Materials and methods

Cells, Ad vectors, and plasmids
Growth conditions for the human MCF10A (Soule et al., 1990 ) and rat12 cells were described earlier (Baluchamy et al., 2003) The Ad vectors expressing FLAG-p300 (Adp300), b-galactosidase (Adb-gal), and Myc responsive reporter cassette (AdM4) were described earlier (Baluchamy et al., 2003) . Adp300sh is an Ad vector expressing sh RNAs using DNA sequence 5 0 -ACCAGATGATGCCTCGAATAA-3 0 ( þ 2501 to þ 2521 from the AUG codon of p300) from human U6 promoter (DNA sequence was chosen using www.genescript.com site). The double stranded oligonucleotide containing sh RNA sequence was first cloned into pSiren-RetroQ vector (BD biosciences) and then transferred to Ad vector. Ad vectors expressing shRNAs directed against YY1, HDAC1 and HDAC3 were constructed based on shRNA sequences published earlier (Ishizuka and Lazar, 2003; Sui et al., 2004) . Del-1 is a human Myc promoter-reporter plasmid containing 2.3 kb upstream promoter sequences (He et al., 1998) . Deletion and substitution mutants of this plasmid were constructed using the Stratagene site directed mutagenesis kit. Other expression plasmids used in this report were HA-p300, FLAG-YY1, FLAG-HDAC3, His-HDAC3, pVR1012p300 and pVR1012DCRD1 (a CMV enhancer driven p300 and a mutant in which aa 1004-1045 were deleted, Girdwood et al., 2003) .
Promoter reporter assays, in vitro and in vivo protein-binding assays, EMSA and ChIP assays Procedures for GST-pull down assays and EMSA were as described (Jayaraman et al., 1999) . For detecting the multiprotein complexes, nuclear extracts were prepared from SaOS2 cells after transfecting with expression plasmids expressing HA-p300, FLAG-YY1 and His-HDAC3 were incubated with an YY1 probe and in the presence of appropriate antibodies for 20 min. Promoter reporter assays were carried out using rat12 cells. Briefly, cells (4-6 Â 10 5 per well) were transfected with Myc promoter-reporter plasmids along with expression plasmids using lipofectamine-2000 (Invitrogen, Carlsbad, CA, USA). Cells were maintained in serum-free media for 48 h, then serum stimulated for 2 h, harvested, and the luciferase activity was determined. ChIP assays were carried out essentially as described (Christova and Oelgeschlager, 2002) . Typically, 5% of the immunoprecipitated sample was used for PCR analysis. The primer pairs used in this study will be available upon request. The PCR generated products were about 150-300 bp in size. The PCR generated products were quantified by quantitative real-time PCR using Applied Biosystems 1200HT system.
